Plain Dealer |
Heart failure breakthrough may come from “open source” cancer drug …
Plain Dealer Dr. James Bradner and Jun Qi work together in a lab at Dana-Farber Cancer Institute. They have been using “crowd-sourcing” – asking for ideas from scientists everywhere – in developing JQ1, a new cancer drug named for Qi. Bradner’s lab worked with Dr. |
Physician continuity after patients leave hospital for heart failure can help … – EurekAlert (press release)
HealthDay |
Physician continuity after patients leave hospital for heart failure can help …
EurekAlert (press release) Patients with heart failure who see a physician in the first month after leaving hospital are more likely to survive than those who do not see a doctor, reports a new study in CMAJ (Canadian Medical Association Journal). The effect is slightly more … UAlberta study shows checkups critical for heart failure patientsHealthCanal.com Heart Failure Survival May Get a Boost From Doctor’s VisitHealthDay Follow-up Key for Heart Failure SurvivaldailyRx |
Blood donation condition relaxed – Belfast Telegraph
Belfast TelegraphBlood donation condition relaxedBelfast TelegraphBlood donation condition relaxed. Comments. Email; Print; Font Size. The IBTS said it will provide a free phlebotomy service for people with hereditary haemochromatosis. 19 August 2013. …
Blood donation condition relaxed – Irish Independent
Irish IndependentBlood donation condition relaxedIrish IndependentBlood donation condition relaxed. Comments. Email; Print; Font Size. The IBTS said it will provide a free phlebotomy service for people with hereditary haemochromatosis. 19 August 2013. …
SeraCare Acquires Reagents and Antibodies Supplier KPL – GenomeWeb
|
SeraCare Acquires Reagents and Antibodies Supplier KPL
GenomeWeb NEW YORK (GenomeWeb News) – SeraCare Life Sciences today said that it has acquired Kirkegaard & Perry Laboratories, a supplier of antibodies and reagents for the life science research and diagnostics markets. Among the products offered by … SeraCare Life Sciences Acquires KPLSan Francisco Chronicle (press release) Linden-Backed SeraCare Acquires Kirkegaard & Perry LabsDow Jones Bankruptcy & Debt (registration) |
Piscataway Health Executive With Personal Connection to Organ Donation … – Local Talk News
Piscataway Health Executive With Personal Connection to Organ Donation …Local Talk NewsThe Piscataway resident said the family did not know that her brother was a registered organ donor until his serious injury and death. She said NJ Sharing Network …
Illumina announces availability of its newest reagent kits for MiSeq benchtop … – News-Medical.net
|
Illumina announces availability of its newest reagent kits for MiSeq benchtop …
News-Medical.net The benefits of increased paired-end read lengths include improving the quality of genome assemblies and advancing applications that require longer read lengths, such as metagenomics and human leukocyte antigen (HLA) typing. “The new MiSeq kits are … Illumina launches new reagent kits for MiSeq benchtop sequencerPharmaceutical Business Review |
RESEARCH AND MARKETS: PharmaPoint: Chronic Heart Failure – Japan Drug … – 4-traders (press release)
RESEARCH AND MARKETS: PharmaPoint: Chronic Heart Failure – Japan Drug …4-traders (press release)The chronic heart failure (CHF) market is a mature market that has been slowly overtaken by generic drugs, and more branded products are expected to lose …
No survival benefit from steroid use in acute liver failure patients – Healio
No survival benefit from steroid use in acute liver failure patientsHealioForty-four percent of patients required liver transplantation. While investigators initially noted improved spontaneous survival among steroid users across the cohort (35% vs. 23…
RESEARCH AND MARKETS: PharmaPoint: Chronic Heart Failure – Italy Drug … – 4-traders (press release)
RESEARCH AND MARKETS: PharmaPoint: Chronic Heart Failure – Italy Drug …4-traders (press release)The chronic heart failure (CHF) market is a mature market that has been slowly overtaken by generic drugs, and more branded products are expected to lose …